Chlamydia serology is indicated to investigate etiology of miscarriage, infertility, PID and ectopic pregnancy. Here, we assessed the reliability of a new automated-multiplex immunofluorescence assay (InoDiag test) to detect specific anti-C. trachomatis IgG.
INTRODUCTION
Prevalence of Chlamydia trachomatis genital infections is steadily increasing over the last decade (Rekart et al., 2013) . The majority of chlamydial infections remain asymptomatic and therefore undetected causing a worldwide silent epidemic (Paavonen, 2012) . Left untreated, Chlamydia trachomatis may lead to ascending infection and tubal damage with chronic sequelae such as tubal infertility and sterility (Baud and Greub, 2011; Paavonen, 2012) . Moreover, Chlamydia trachomatis is recognised as an agent of miscarriage . Although PCR represents the ideal diagnostic approach for uretritis and cervicitis, serology remains useful to detect anti-chlamydial antibodies among women with tubal infertility, ectopic pregnancy, miscarriage, pelvic inflammatory disease and chronic pelvic pain (Baud et al., 2008; Baud and Greub, 2011; Haggerty et al., 2010) , since in such chronic conditions, the negative predictive value is very high. Microimmunofluorescence assay (IF), still considered as the "gold standard" for the serology of this pathogen, has the disadvantage to be timeconsuming, subjective and reader-dependant (Gaydos C and Essig A, 2011) . However, enzymelinked immunosorbent assays (ELISA) using the major outer membrane protein (MOMP) as antigen appears to exhibit a higher sensitivity for diagnosing chlamydial infections (Baud et al., 2010 
METHOD
Studied sera were obtained from women with and without miscarriages as described previously by Baud et al. (Baud et al., 2007; Baud et al., 2009; Baud et al., 2010) . A total of 265 sera were tested for the presence of Chlamydia trachomatis IgG antibodies with the new automated "multiplexed serology test" (Mu.S.T) as previously described (Baud et al., 2010; Gouriet et al., 2008a; Gouriet et al., 2008b) pELISA, R-Biopharm, Darmstadt, Germany. All these 3 commercial tests were performed according to the manufacturers' instructions.
To evaluate cross-reactivity, serum samples collected from patients with positive serologies against Toxoplasma gondii (n=81 cases), Waddlia chondrophila (n=83), Chlamydia psittaci (n=24), Chlamydia pneumoniae (n=96) and Brucella sp (n=11) were also analysed and the risk of cross-reactivity with Chlamydia trachomatis was statistically determined. All these serological tests were performed using commercial kits previously reported (Baud et al., 2007 , Baud et al., 2010 and for Waddlia chondrophila using an home made immunofluorescence as earlier described (Baud et al., 2007) .
To compare all five serological tests, the sensitivities, specificities, positive predictive values threshold for negativity and positivity, as defined by the manufacturer of MOMP-Medac and MOMP-RB) were excluded from these analyses. To assess cross-reactivity, we compared the correlation between serology directed against two different pathogens using the Chi 2 test.
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RESULTS

Of the 265 sera, Chlamydia trachomatis
All 6 tests cross-reacted with C. psittaci (p<0.001) and C. pneumoniae (p<0.05 -0.001) as shown in Table 2 . Moreover, IF also cross-reacted significantly with T. gondii and W. chondrophila (Table 1) . InoDiag-MOMP showed the lowest cross-reactivity rate, with the different investigated species.
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DISCUSSION
In this study, we assessed the performance of an automated multiplex antigen microarray (InoDiag) for the detection of Chlamydia trachomatis IgG antibodies.
The specificity of the Inodiag assays (94.6%-98%) was higher than the two commercialized ELISA used for comparison, whereas sensitivities were similar (65.5%-72.4%). In the present study, we showed that sensitivity was not improved by MOMP alone compared to EBs.
However, the combination of MOMP and EBs by Inodiag increased sensitivity without altering specificity. All the tests studied here show low PPV, indicating that confirmation is required when positive as suggested by others (Mylonas, 2012) . Moreover, we would recommend to use a second serological assay in case of doubtful result (grey zone). In contrast to our study, Muvunyi et al. showed that peptide-based ELISA performed as well as two different IF assays (Muvunyi et al, 2012) . However, the performance of the InoDiag tests presented here are consistent with previous studies that revealed good sensitivities and specificities of ELISA assays based on peptides from the MOMP (Muvunyi et al, 2012 ; Land JA et al, 2003) .The new automated microarray from Inodiag® show similar performance than ELISA. It is well designed for small laboratories, since batches of only 2 to 4 samples can be tested with InoDiag. Several pathogens can be tested simultaneously, allowing pathology-driven testing instead of the common pathogen-driven testing (Gouriet et al., 2008a; Gouriet et al., 2008b; Raoult et al., 2004) . Moreover, thank to the multiplex format of the Inodiag technology,
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